EMERYVILLE, Calif.--(BUSINESS WIRE)--Amyris, Inc. (NASDAQ:AMRS) announced today that it has entered into a contract manufacturing agreement with Antibióticos, S.A. Under this arrangement, Antibióticos will work with Amyris to produce farnesene at its facilities in León, Spain; the produced farnesene will be owned and distributed by Amyris.
